5-vial packs save 20% · 15% off single-vial subtotals over $250 · Discounts do not stack
Synova Biotech
Home / Research catalogue / Retatrutide
Synova Biotech Retatrutide 10 mg vial

CANADIAN PEPTIDE RESEARCH SUPPLY

Retatrutide

10 mg

A research-stage triple receptor agonist active at GIP, GLP-1 and glucagon receptors, investigated in studies of receptor activity, energy-balance pathways, glucose regulation and metabolic signalling.

Silver cap vial

$84.99 CAD

Single vial · $84.99 CAD

5-vial pack · $339.96 CAD · Save 20%

5 vials, each 10 mg. Pack savings cannot be combined with other discounts.

View COA

Research topics

  • GIP receptor activity
  • GLP-1 receptor activity
  • Glucagon receptor activity
  • Metabolic signalling

Related literature

Independent scientific literature supplied for convenient reference.

Retatrutide phase 2 trialRetatrutide trial
Product classification: Supplied for laboratory research and analytical use. Product descriptions summarize research topics and do not constitute medical advice or establish suitability for any particular application.